The use of antibody-based tests (IgG, IgA) for the detection of H. pylori in serum, whole blood, urine and saliva in clinical settings is discouraged. Exceptions are patients on PPIs, preparations of bismuth or antibiotic therapy, in whom treatment cannot be interrupted and diagnosis requires exclusion of H. pylori infection.

Quality of evidence: high. Recommendation: strong.